Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mesa Laboratories (MLAB) Debt to Equity (2016 - 2025)

Mesa Laboratories' Debt to Equity history spans 15 years, with the latest figure at $0.55 for Q4 2025.

  • For Q4 2025, Debt to Equity fell 47.64% year-over-year to $0.55; the TTM value through Dec 2025 reached $0.55, down 47.64%, while the annual FY2025 figure was $0.44, 27.27% up from the prior year.
  • Debt to Equity for Q4 2025 was $0.55 at Mesa Laboratories, down from $0.59 in the prior quarter.
  • Across five years, Debt to Equity topped out at $1.06 in Q4 2024 and bottomed at $0.01 in Q2 2023.
  • The 5-year median for Debt to Equity is $0.25 (2024), against an average of $0.34.
  • The largest annual shift saw Debt to Equity surged 11159.96% in 2021 before it crashed 89.56% in 2023.
  • A 5-year view of Debt to Equity shows it stood at $0.15 in 2021, then tumbled by 67.59% to $0.05 in 2022, then skyrocketed by 213.56% to $0.15 in 2023, then skyrocketed by 587.56% to $1.06 in 2024, then plummeted by 47.64% to $0.55 in 2025.
  • Per Business Quant, the three most recent readings for MLAB's Debt to Equity are $0.55 (Q4 2025), $0.59 (Q3 2025), and $0.4 (Q2 2025).